APLM
APLM
NASDAQ · Biotechnology

Apollomics Inc

$14.36
+0.76 (+5.59%)
As of May 16, 2:26 AM ET ·
Financial Highlights (FY 2026)
Revenue
12.23M
Net Income
-15,733,887
Gross Margin
Profit Margin
-128.7%
Rev Growth
D/E Ratio
0.20
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 40.8% 40.8% 40.8%
Operating Margin -131.8% -4.0% -3.7% -4.4%
Profit Margin -128.7% -4.3% -4.8% -4.4%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 12.23M 4.59M 4.05M 3.58M
Gross Profit 1.87M 1.65M 1.46M
Operating Income -16,112,438 -182,237 -150,486 -157,185
Net Income -15,733,887 -196,564 -196,089 -156,693
Gross Margin 40.8% 40.8% 40.8%
Operating Margin -131.8% -4.0% -3.7% -4.4%
Profit Margin -128.7% -4.3% -4.8% -4.4%
Rev Growth +16.2% +0.5% -3.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 2.47M 9.54M 7.54M 8.50M
Total Equity 12.46M 8.98M 8.14M 8.85M
D/E Ratio 0.20 1.06 0.93 0.96
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -15,282,356 -265,994 -241,454 -219,779
Free Cash Flow -252,687 -239,821 -142,632